
PHAXIAM takes stock of its activities and publishes its results for the first half of 2023 – 09/21/2023 at 10:05 p.m.
Creation of PHAXIAM Therapeutics with effect from June 23, 2023, in order to form a world leader in phage therapy targeting high value-added indications Development of an ambitious and value-creating clinical and regulatory strategy in the field of severe and resistant bacterial infectionso Launch of a first global pivotal phase 2b/3 study in osteoarticular prosthesis…